Ikarian Capital, LLC - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 240 filers reported holding NEKTAR THERAPEUTICS in Q3 2021. The put-call ratio across all filers is 0.30 and the average weighting 0.1%.

Quarter-by-quarter ownership
Ikarian Capital, LLC ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q1 2022$722,000
-78.6%
133,900
-46.4%
0.10%
-81.1%
Q4 2021$3,378,000
+63.8%
250,000
+117.8%
0.50%
+246.9%
Q3 2021$2,062,000
-19.1%
114,800
-23.5%
0.14%
+29.5%
Q4 2020$2,550,000
+2.5%
150,0000.0%0.11%
-37.8%
Q3 2020$2,488,000
-28.4%
150,0000.0%0.18%
-34.8%
Q2 2020$3,474,000150,0000.28%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q3 2021
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 1,828,400$89,281,0006.61%
Cormorant Asset Management, LP 1,500,000$73,245,0005.42%
Camber Capital Management LP 2,000,000$97,660,0003.76%
Rhenman & Partners Asset Management AB 617,652$30,160,0003.09%
BRIDGER MANAGEMENT, LLC 1,134,414$55,393,0003.00%
First Light Asset Management, LLC 374,251$18,275,0002.84%
Gs Investments, Inc. 54,000$2,636,820,0001.97%
SABBY MANAGEMENT, LLC 241,922$11,813,0001.82%
QUANTRES ASSET MANAGEMENT Ltd 50,000$2,441,0001.41%
Tibra Equities Europe Ltd 173,183$8,457,0001.27%
View complete list of NEKTAR THERAPEUTICS shareholders